Consistent with previous research, GBM cell apoptosis related proteins were also changed after 5-DMN treatment, including caspase-9 and caspase-3 activation; the Bcl-2 was down-regulated, while the Bax was up-regulated. The gene discussed is CASP3; the disease is glioblastoma.